SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
X QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended May 31, 2003 File Number 0-288
Robbins & Myers, Inc
| Ohio (State or other jurisdiction of incorporation or organization) |
31-0424220 (I.R.S. Employer Identification No.) |
| 1400 Kettering Tower, Dayton, Ohio (Address of Principal executive offices) |
45423 (Zip Code) |
Registrants telephone number including area code (937) 222-2610
None
Former name, former address and former fiscal year if changed since last report
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. YES X NO
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). YES X NO
Common shares, without par value, outstanding as of May 31, 2003: 14,378,600
1
ROBBINS & MYERS, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED BALANCE SHEET
(In thousands)
| May 31, | August 31, | ||||||||||
| 2003 | 2002 | ||||||||||
ASSETS |
(Unaudited) | ||||||||||
Current Assets
|
|||||||||||
Cash and cash equivalents |
$ | 9,196 | $ | 10,534 | |||||||
Accounts receivable |
113,089 | 113,711 | |||||||||
Inventories: |
|||||||||||
Finished products |
28,116 | 29,000 | |||||||||
Work in process |
35,792 | 22,487 | |||||||||
Raw materials |
40,760 | 40,959 | |||||||||
| 104,668 | 92,446 | ||||||||||
Other current assets |
10,933 | 12,318 | |||||||||
Deferred taxes |
13,607 | 14,071 | |||||||||
Total Current Assets |
251,493 | 243,080 | |||||||||
Goodwill |
302,021 | 271,948 | |||||||||
Other Intangible Assets |
17,535 | 17,604 | |||||||||
Other Assets |
6,991 | 6,201 | |||||||||
Property, Plant and Equipment |
286,168 | 261,926 | |||||||||
Less accumulated depreciation |
(138,975 | ) | (118,067 | ) | |||||||
| 147,193 | 143,859 | ||||||||||
| $ | 725,233 | $ | 682,692 | ||||||||
LIABILITIES
AND SHAREHOLDERS EQUITY
|
|||||||||||
Current Liabilities
|
|||||||||||
Accounts payable |
$ | 48,464 | $ | 41,964 | |||||||
Accrued expenses |
85,810 | 83,871 | |||||||||
Current portion of long-term debt |
7,346 | 4,526 | |||||||||
Total Current Liabilities |
141,620 | 130,631 | |||||||||
Long-Term DebtLess Current Portion |
192,658 | 203,920 | |||||||||
Deferred Taxes |
8,827 | 8,708 | |||||||||
Other Long-Term Liabilities |
79,275 | 70,863 | |||||||||
Minority Interest |
9,116 | 8,347 | |||||||||
Shareholders Equity
|
|||||||||||
Common stock |
104,306 | 103,923 | |||||||||
Retained earnings |
183,702 | 176,627 | |||||||||
Accumulated other comprehensive loss |
5,729 | (20,057 | ) | ||||||||
| 293,737 | 260,493 | ||||||||||
| $ | 725,233 | $ | 682,692 | ||||||||
See Notes to Consolidated Condensed Financial Statements
2
ROBBINS & MYERS, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED INCOME STATEMENT
(In thousands, except per share data)
(Unaudited)
| Three Months Ended | Nine Months Ended | ||||||||||||||||
| May 31, | May 31, | ||||||||||||||||
| 2003 | 2002 | 2003 | 2002 | ||||||||||||||
Net sales |
$ | 144,921 | $ | 124,812 | $ | 403,904 | $ | 394,201 | |||||||||
Cost of sales |
95,782 | 83,419 | 267,970 | 262,342 | |||||||||||||
Gross profit |
49,139 | 41,393 | 135,934 | 131,859 | |||||||||||||
SG&A expenses |
37,146 | 31,640 | 106,938 | 97,073 | |||||||||||||
Amortization expense |
554 | 388 | 1,664 | 1,569 | |||||||||||||
Other |
0 | 0 | 0 | 0 | |||||||||||||
Income before interest and income taxes |
11,439 | 9,365 | 27,332 | 33,217 | |||||||||||||
Interest expense |
4,000 | 4,909 | 11,710 | 13,528 | |||||||||||||
Income before income taxes and minority
interest |
7,439 | 4,456 | 15,622 | 19,689 | |||||||||||||
Income tax expense |
2,488 | 1,490 | 5,230 | 6,590 | |||||||||||||
Minority interest |
540 | 270 | 948 | 792 | |||||||||||||
Net income |
$ | 4,411 | $ | 2,696 | $ | 9,444 | $ | 12,307 | |||||||||
Net income per share: |
|||||||||||||||||
Basic |
$ | 0.31 | $ | 0.23 | $ | 0.66 | $ | 1.04 | |||||||||
Diluted |
$ | 0.30 | $ | 0.23 | $ | 0.66 | $ | 0.99 | |||||||||
Dividends per share: |
|||||||||||||||||
Declared |
$ | 0.055 | $ | 0.055 | $ | 0.165 | $ | 0.165 | |||||||||
Paid |
$ | 0.055 | $ | 0.055 | $ | 0.165 | $ | 0.165 | |||||||||
See Notes to Consolidated Condensed Financial Statements
3
ROBBINS & MYERS, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENT OF CASH FLOWS
(In thousands)
(Unaudited)
| Nine Months Ended | ||||||||||||
| May 31, | ||||||||||||
| 2003 | 2002 | |||||||||||
Operating Activities: |
||||||||||||
Net income |
$ | 9,444 | $ | 12,307 | ||||||||
Adjustments to reconcile net income to net cash and
cash equivalents provided by operating activities: |
||||||||||||
Depreciation |
15,588 | 15,286 | ||||||||||
Amortization |
1,664 | 1,569 | ||||||||||
Deferred taxes |
345 | (423 | ) | |||||||||
Performance stock awards |
0 | (126 | ) | |||||||||
Changes in operating assets and liabilities: |
||||||||||||
Accounts receivable |
12,365 | 3,204 | ||||||||||
Inventories |
(809 | ) | 15,071 | |||||||||
Accounts payable |
1,638 | (5,189 | ) | |||||||||
Accrued expenses |
(6,210 | ) | (7,722 | ) | ||||||||
Other |
(69 | ) | (3,238 | ) | ||||||||
Net Cash and Cash Equivalents Provided by Operating Activities |
33,956 | 30,739 | ||||||||||
Investing Activities: |
||||||||||||
Capital expenditures, net of nominal disposals |
(4,397 | ) | (12,648 | ) | ||||||||
Purchase of Tarby |
(12,478 | ) | 0 | |||||||||
Proceeds from sale of equipment |
0 | 4,905 | ||||||||||
Amended credit agreement fees |
0 | (1,871 | ) | |||||||||
Romaco earnout payment and acquisition costs |
0 | (19,794 | ) | |||||||||
Net Cash and Cash Equivalents Used by Investing Activities |
(16,875 | ) | (29,408 | ) | ||||||||
Financing Activities: |
||||||||||||
Proceeds from debt borrowings |
49,731 | 31,083 | ||||||||||
Payments of long-term debt |
(66,164 | ) | (43,274 | ) | ||||||||
Proceeds from sale of common stock |
383 | 3,755 | ||||||||||
Dividends paid |
(2,369 | ) | (1,951 | ) | ||||||||
Net Cash and Cash Equivalents Used by Financing Activities |
(18,419 | ) | (10,387 | ) | ||||||||
Decrease in Cash and Cash Equivalents |
(1,338 | ) | (9,056 | ) | ||||||||
Cash and Cash Equivalents at Beginning of Period |
10,534 | 16,122 | ||||||||||
Cash and Cash Equivalents at End of Period |
$ | 9,196 | $ | 7,066 | ||||||||
See Notes to Consolidated Condensed Financial Statements
4
ROBBINS & MYERS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
May 31, 2003
(Unaudited)
NOTE 1Preparation of Financial Statements
While we believe that the disclosures are adequately presented, it is suggested that these consolidated condensed financial statements be read in conjunction with the financial statements and notes included in our most recent Annual Report on Form 10-K for the fiscal year ended August 31, 2002. A summary of our significant accounting policies is presented therein on page 34. There have been no material changes in the accounting policies followed by us during fiscal year 2003.
NOTE 2New Accounting Standards
In December 2002, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards No. 148 (SFAS 148), Accounting for Stock-Based Compensation Transition and Disclosure. This Statement amends FASB Statement No. 123, Accounting for Stock-Based Compensation, to provide alternative methods of transition for a voluntary change to the fair value based method of accounting for stock-based employee compensation. In addition, this Statement amends the disclosures in both annual and interim financial statements regarding the method of accounting for stock-based employee compensation and the effect of the method used on reported results. We continue to apply Accounting Principles Board Opinion No. 25 for the method used to account for stock-based employee compensation arrangements, where applicable, but have adopted the new disclosure requirements of SFAS 148 (see Note 9).
NOTE 3Acquisition
5
NOTE 4Goodwill and Other Intangible Assets
| Pharmaceutical | Energy | Industrial | ||||||||||||||
| Segment | Segment | Segment | Total | |||||||||||||
| (In thousands) | ||||||||||||||||
Balance as of September 1, 2002 |
$ | 161,138 | $ | 68,098 | $ | 42,712 | $ | 271,948 | ||||||||
Goodwill acquired during the period |
0 | 0 | 8,384 | 8,384 | ||||||||||||
Translation adjustments and other |
19,823 | 1,588 | 278 | 21,689 | ||||||||||||
Balance as of May 31, 2003 |
$ | 180,961 | $ | 69,686 | $ | 51,374 | $ | 302,021 | ||||||||
Information regarding our other intangible assets is as follows:
| As of May 31, 2003 | As of August 31, 2002 | ||||||||||||||||||||||||
| Carrying | Accumulated | Carrying | Accumulated | ||||||||||||||||||||||
| Amount | Amortization | Net | Amount | Amortization | Net | ||||||||||||||||||||
| (In thousands) | |||||||||||||||||||||||||
Patents and
Trademarks |
8,117 | $ | 1,626 | $ | 6,491 | $ | 7,260 | $ | 1,103 | $ | 6,157 | ||||||||||||||
Non-compete
Agreements |
10,752 | 8,199 | 2,553 | 10,752 | 7,823 | 2,929 | |||||||||||||||||||
Financing
Costs |
7,366 | 4,068 | 3,298 | 6,668 | 3,363 | 3,305 | |||||||||||||||||||
Pension
Intangible |
4,564 | 0 | 4,564 | 4,564 | 0 | 4,564 | |||||||||||||||||||
Other |
2,078 | 1,449 | 629 | 2,038 | 1,389 | 649 | |||||||||||||||||||
Total |
$ | 32,877 | $ | 15,342 | $ | 17,535 | $ | 31,282 | $ | 13,678 | $ | 17,604 | |||||||||||||
6
NOTE 5Net Income per Share
| Three Months Ended | Nine Months Ended | ||||||||||||||||||
| May 31, | May 31, | ||||||||||||||||||
| 2003 | 2002 | 2003 | 2002 | ||||||||||||||||
| (In thousands, except per share amounts) | |||||||||||||||||||
Numerator: |
|||||||||||||||||||
Basic: |
|||||||||||||||||||
Net income |
$ | 4,411 | $ | 2,696 | $ | 9,444 | $ | 12,307 | |||||||||||
Effect of dilutive securities: |
|||||||||||||||||||
Convertible debt interest |
575 | 582 | 1,757 | 1,746 | |||||||||||||||
Income attributable to diluted shares |
$ | 4,986 | $ | 3,278 | $ | 11,201 | $ | 14,053 | |||||||||||
Denominator: |
|||||||||||||||||||
Basic: |
|||||||||||||||||||
Weighted average shares |
14,373 | 11,894 | 14,358 | 11,833 | |||||||||||||||
Effect of dilutive securities: |
|||||||||||||||||||
Convertible debt |
2,135 | 2,191 | 2,194 | 2,191 | |||||||||||||||
Dilutive options and restricted shares |
26 | 118 | 29 | 138 | |||||||||||||||
Diluted shares |
16,534 | ||||||||||||||||||